MAIA Biotechnology Inc.

AMEX: MAIA · Real-Time Price · USD
1.57
0.01 (0.64%)
At close: Aug 15, 2025, 12:38 PM

MAIA Biotechnology Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.6M 7.15M 10.95M 10.57M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2.8K 2.8K 214K 654.7K
Receivables
77.35K 144.68K 302.79K 43.67K
Inventory
n/a n/a n/a -43.67K
Other Current Assets
473.83K 268.68K 554.32K n/a
Total Current Assets
10.15M 7.56M 11.81M 10.67M
Property-Plant & Equipment
n/a n/a n/a n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
2.8K 2.8K 214K 654.7K
Total Assets
10.16M 7.57M 12.02M 11.33M
Account Payables
1.51M 1.64M 1.17M 960.4K
Deferred Revenue
n/a n/a n/a 111.27K
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
941.1K 1.61M n/a 689.57K
Total Current Liabilities
3.83M 4.94M 3.27M 2.15M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
2.69M 2.15M 245.34K n/a
Total Long-Term Liabilities
2.69M 2.15M 245.34K n/a
Total Liabilities
6.52M 7.09M 3.51M 2.15M
Total Debt
n/a n/a n/a n/a
Common Stock
2.62K 1.7K 1.1K 758.00
Retained Earnings
-87.23M -63.98M -44.21M -28.44M
Comprehensive Income
-30.61K -16.26K -15.97K n/a
Shareholders Equity
3.63M 477.51K 8.51M 9.18M
Total Investments
n/a n/a n/a n/a